Excellent effects and possible mechanisms of action of a new antibody–drug conjugate against EGFR-positive triple-negative breast cancer

BACKGROUND: Triple-negative breast cancer (TNBC) is the most aggressive subtype and occurs in approximately 15–20% of diagnosed breast cancers. TNBC is characterized by its highly metastatic and recurrent features, as well as a lack of specific targets and targeted therapeutics. Epidermal growth fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Dan-Dan, Bai, Wei-Qi, Zhai, Xiao-Tian, Sun, Li-Ping, Zhen, Yong-Su, Li, Zhuo-Rong, Miao, Qing-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656065/
https://www.ncbi.nlm.nih.gov/pubmed/34879870
http://dx.doi.org/10.1186/s40779-021-00358-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656065/
https://www.ncbi.nlm.nih.gov/pubmed/34879870
http://dx.doi.org/10.1186/s40779-021-00358-9

Ejemplares similares